Biotech Bet

Export thrust and focus on new lifestyle and biotech products are yielding results for Wockhardt

Wockhardt, the fifth largest pharma company in the country, has turned in an improved performance in the first six months of this calendar year. Its profits have surged 71 per cent over the previous year.

The improved performance has been attributed to the company